Birchview Capital’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Birchview Capital's GOSS Position: Q2 2026 in Review
Birchview Capital held its Gossamer Bio (GOSS) position steady in Q2 2026 at 18,176 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #72.
Birchview Capital first reported a position in GOSS in Q4 2019 and has held it in 21 quarters since. The position peaked at $1.91M in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Birchview Capital held 18,176 shares of Gossamer Bio worth $2.99K as of Q2 2026.
- Birchview Capital left its Gossamer Bio share count unchanged in Q2 2026.
- Gossamer Bio made up ﹤0.01% of Birchview Capital's portfolio in Q2 2026, its #72 holding.
- Birchview Capital first reported a position in Gossamer Bio in Q4 2019 and has held it in 21 quarters since.
- Birchview Capital's Gossamer Bio position peaked at $1.91M in Q3 2022.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Birchview Capital's 13F filing for Q2 2026, filed 14 Aug 2026.